Gastric Insufflation and Laryngeal Mask Airway

Lionel Bouvet

Status: Unknown

Conditions: Gastric Insufflation

Treatments: Device: AuraOnceTM; Device: LMA SupremeTM

Study type: Interventional

Funder types: Other

Identifiers

NCT02097771

2013-A01852-43

Details and patient eligibility

About

Comparison of the incidence of gastric insufflation between two kinds of laryngeal masks airways: LMA SupremeTM vs Ambu AuraOnceTM

Sex: All

Ages: 18 to 95 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA 1 or 2
• Age > 18 yrs
• Use of laryngeal mask airway required

Exclusion criteria

• risk of pulmonary aspiration of gastric contents
• Contraindication for the use of laryngeal mask airway
• Tracheal intubation required
• Patient's refusal

Trial design

0 participants in 2 patient groups

LMA SupremeTM

Active Comparator group

Treatment:

Device: LMA SupremeTM

Ambu AuraOnce

Sham Comparator group

Treatment:

Device: AuraOnceTM